Schmitz G, Roth B
Am J Physiol Cell Physiol. 2023; 325(1):C17-C28.
PMID: 37067459
PMC: 10281788.
DOI: 10.1152/ajpcell.00397.2022.
Friedman J, Lindenmayer J, Alcantara F, Bowler S, Parak M, White L
Neuropsychopharmacology. 2011; 36(6):1289-95.
PMID: 21346734
PMC: 3077468.
DOI: 10.1038/npp.2011.14.
Iversen L
Proc R Soc Med. 2010; 70(Suppl 10):1-4.
PMID: 20919311
PMC: 1542815.
Nickla D, Totonelly K, Dhillon B
Exp Eye Res. 2010; 91(5):715-20.
PMID: 20801115
PMC: 2962673.
DOI: 10.1016/j.exer.2010.08.021.
Gozzi A, Crestan V, Turrini G, Clemens M, Bifone A
Psychopharmacology (Berl). 2010; 209(1):37-50.
PMID: 20111859
DOI: 10.1007/s00213-009-1772-4.
Development and application of hybrid structure based method for efficient screening of ligands binding to G-protein coupled receptors.
Kortagere S, Welsh W
J Comput Aided Mol Des. 2006; 20(12):789-802.
PMID: 17054015
PMC: 2756463.
DOI: 10.1007/s10822-006-9077-8.
A rat model of distractibility: effects of drugs modifying dopaminergic, noradrenergic and GABAergic neurotransmission.
Agmo A, Belzung C, Rodriguez C
J Neural Transm (Vienna). 1997; 104(1):11-29.
PMID: 9085190
DOI: 10.1007/BF01271291.
The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin.
Monnet F, Debonnel G, Bergeron R, Gronier B, De Montigny C
Br J Pharmacol. 1994; 112(2):709-15.
PMID: 8075892
PMC: 1910385.
DOI: 10.1111/j.1476-5381.1994.tb13134.x.
Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus.
Monnet F, Mahe V, Robel P, Baulieu E
Proc Natl Acad Sci U S A. 1995; 92(9):3774-8.
PMID: 7731982
PMC: 42044.
DOI: 10.1073/pnas.92.9.3774.
Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine. 1984.
Barnett A, Iorio L, Kreutner W, Tozzi S, Ahn H, GULBENKIAN A
Agents Actions. 1994; 43(3-4):149-56; discussion 157.
PMID: 7725966
DOI: 10.1007/BF01986682.
Trifluoperazine and calmidazolium have multiple actions on the release of noradrenaline from sympathetic nerves of mouse atria.
Barrington M, Majewski H
Naunyn Schmiedebergs Arch Pharmacol. 1994; 349(2):133-9.
PMID: 7513380
DOI: 10.1007/BF00169829.
The locomotor effect of clonidine and its interaction with alpha-flupenthixol or haloperidol in the developing rat.
Nomura Y
Naunyn Schmiedebergs Arch Pharmacol. 1980; 313(1):33-7.
PMID: 7207635
DOI: 10.1007/BF00505802.
Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
List S, Seeman P
Proc Natl Acad Sci U S A. 1981; 78(4):2620-4.
PMID: 6941314
PMC: 319401.
DOI: 10.1073/pnas.78.4.2620.
Effects of chronic treatment with antidepressants on aggressiveness induced by clonidine in mice.
Maj J, Rogoz Z, Skuza G, SOWINSKA H
J Neural Transm. 1982; 55(1):19-25.
PMID: 6813425
DOI: 10.1007/BF01243338.
Interactions of a neuroleptic drug (fluphenazine) with catecholamines in hippocampus.
Palmer M, Freedman R, Dunwiddie T
Psychopharmacology (Berl). 1982; 76(2):122-9.
PMID: 6805021
DOI: 10.1007/BF00435265.
An involvement of dopamine in higher order choice mechanisms in the monkey.
Ridley R, Haystead T, Baker H
Psychopharmacology (Berl). 1981; 72(2):173-7.
PMID: 6782607
DOI: 10.1007/BF00431652.
Chronic treatment with antidepressants: protentiation of clonidine-induced aggression in mice via noradrenergic mechanism.
Maj J, Mogilnicka E, Klimek V
J Neural Transm. 1981; 52(3):189-97.
PMID: 6458665
DOI: 10.1007/BF01249603.
Effects of naloxone on methamphetamine and apomorphine stereotypy and on haloperidol catalepsy in rats.
Balsara J, Nandal N, Burte N, Jadhav J, Chandorkar A
Psychopharmacology (Berl). 1984; 82(3):237-40.
PMID: 6425907
DOI: 10.1007/BF00427781.
Diazepam potentiates the effect of neuroleptics on behavioural activity as well as dopamine and norepinephrine turnover: Do benzodiazepines have antipsychotic potency?.
Singhal R, Rastogi R, Lapierre Y
J Neural Transm. 1983; 56(2-3):127-38.
PMID: 6306165
DOI: 10.1007/BF01243272.
Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine.
Barnett A, Iorio L, Kreutner W, Tozzi S, Ahn H, GULBENKIAN A
Agents Actions. 1984; 14(5-6):590-7.
PMID: 6236679
DOI: 10.1007/BF01978891.
